🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/06/2007 | 24,78 | 24,85 | 23,92 | 24,48 | -1,06% | 3,78% | 270.907 |
| 31/05/2007 | 24,03 | 25,00 | 24,03 | 24,74 | +2,80% | 4,05% | 164.682 |
| 30/05/2007 | 25,64 | 26,05 | 23,84 | 24,07 | -6,27% | 8,61% | 421.108 |
| 29/05/2007 | 25,64 | 25,79 | 25,60 | 25,68 | +0,15% | 0,73% | 76.196 |
| 25/05/2007 | 25,83 | 25,83 | 25,60 | 25,64 | +0,00% | 0,87% | 86.295 |
| 24/05/2007 | 25,64 | 25,79 | 25,60 | 25,64 | +0,00% | 0,73% | 100.081 |
| 23/05/2007 | 25,38 | 26,05 | 25,19 | 25,64 | +0,59% | 3,39% | 190.597 |
| 22/05/2007 | 24,44 | 25,90 | 24,40 | 25,49 | +3,81% | 6,13% | 193.616 |
| 21/05/2007 | 24,48 | 24,78 | 24,29 | 24,55 | -0,15% | 1,99% | 435.722 |
| 18/05/2007 | 24,67 | 24,85 | 24,48 | 24,59 | -0,45% | 1,52% | 227.386 |
| 17/05/2007 | 24,40 | 25,08 | 24,40 | 24,70 | +0,76% | 2,76% | 164.120 |
| 16/05/2007 | 24,59 | 24,78 | 24,22 | 24,52 | -0,61% | 2,28% | 196.448 |
| 15/05/2007 | 25,23 | 25,38 | 24,59 | 24,67 | -2,37% | 3,12% | 101.684 |
| 14/05/2007 | 25,60 | 26,13 | 25,27 | 25,27 | -1,75% | 3,36% | 676.039 |
| 11/05/2007 | 26,35 | 26,58 | 25,38 | 25,71 | -0,15% | 4,55% | 187.791 |
| 10/05/2007 | 25,56 | 25,98 | 25,34 | 25,75 | -0,43% | 2,49% | 183.196 |
| 09/05/2007 | 25,30 | 25,98 | 25,27 | 25,86 | +1,62% | 2,81% | 95.512 |
| 08/05/2007 | 25,64 | 25,83 | 25,30 | 25,45 | -0,15% | 2,04% | 77.986 |
| 07/05/2007 | 26,16 | 26,16 | 25,30 | 25,49 | -2,57% | 3,29% | 167.514 |
| 04/05/2007 | 26,84 | 26,84 | 26,13 | 26,16 | -2,37% | 2,65% | 226.771 |
| 03/05/2007 | 26,61 | 26,99 | 26,54 | 26,80 | -0,56% | 1,69% | 173.204 |
| 02/05/2007 | 25,83 | 27,06 | 25,79 | 26,95 | +4,20% | 4,93% | 344.324 |
| 01/05/2007 | 25,38 | 26,16 | 25,38 | 25,86 | +1,47% | 3,10% | 477.186 |
| 30/04/2007 | 26,24 | 26,31 | 25,34 | 25,49 | -3,27% | 3,71% | 186.616 |
| 27/04/2007 | 26,46 | 26,65 | 26,20 | 26,35 | -0,56% | 1,70% | 72.696 |
| 26/04/2007 | 26,76 | 26,80 | 26,16 | 26,50 | -0,56% | 2,38% | 193.776 |
| 25/04/2007 | 26,01 | 26,69 | 26,01 | 26,65 | +2,15% | 2,59% | 296.101 |
| 24/04/2007 | 26,58 | 26,76 | 25,71 | 26,09 | -2,24% | 3,94% | 219.130 |
| 23/04/2007 | 26,95 | 27,06 | 26,24 | 26,69 | -0,28% | 3,06% | 212.478 |
| 20/04/2007 | 27,06 | 27,06 | 26,54 | 26,76 | +0,70% | 1,94% | 139.942 |